BioPharma

A recent study found that 86.9% of biopharmaceutical companies outsource at least some of their work. This has helped to build the $14 billion biopharmaceutical contract manufacturing business. The researchers forecast a highly promising and profitable future for biopharmaceutical contract...

In today's fast-paced market, biotech firms continue to encounter many hurdles, especially during the clinical phase of drug development. Biologics may pose significant technical and commercial risks due to their exorbitant prices, intricate production procedures, and regulatory barriers. Nevertheless,...

According to a recent analysis released by MarketsandMarkets, the injectable medication delivery market is expected to grow at a compound annual growth rate (CAGR) of about 9% between 2024 and 2029. By 2029, this market is projected to be worth...

It is noteworthy that cell and gene therapies, or CGTs, have shown great promise in the treatment of a variety of illnesses, including cancer and neurological disorders. However, in addition to their possible benefits, they also pose serious and...

In the high-stakes arena of biomanufacturing, where tiny contaminants can have macroscopic effects, the idea of fluid channel integrity has developed from an operational need into a vital pillar of product assurance.  Maintaining an uncompromised fluid path from upstream...

Automation in Fluid Transfer: From Manual to Modular Systems in Biomanufacturing A fundamental component of biomanufacturing, fluid transfer links upstream and downstream processes and enables the flow of precious biomaterials.  Historically, fluid transfer depended mostly on human operations—tubing changes, valve...

Smart Sensors & Monitoring in Fluid Systems in Biomanufacturing Precision and consistency are not just wanted in the rapidly changing biomanufacturing sector; they are absolutely vital.  The function of smart sensors and monitoring systems in fluid management has grown basic...